Invesaro

Stocks Health care CHUC

OTC · Health care

Charlie's Holdings, Inc. (CHUC)

Charlie's Holdings, Inc. brought in $26.2M of revenue over the twelve months to June 30, 2026, up 335.7% from a year earlier. It posted a net loss of $2M. In fiscal 2025 capital spending exceeded operating cash flow by $5.8M. At June 30, 2026 it held $527K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 17, 2026.

Watch CHUC in 60 seconds
Price
$0.16
+10.43% on the day · September 28, 2026
52-week range $0.14 to $0.37
Market cap
$45.4M
Revenue (last 12 months)
$26.2M
+335.7% year on year
Net margin
-7.5%
P/E
8.1
on FY2025 diluted EPS

What Charlie's Holdings, Inc. does

Charlie's Holdings, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CHUC.

Revenue and profit by year

Revenue
FY20: $16.7M $16.7M FY20FY21: $21.5M $21.5M FY21FY22: $26.4M $26.4M FY22FY23: $16.3M $16.3M FY23FY24: $7.8M $7.8M FY24FY25: $20.9M $20.9M FY25
Net income
FY21: -$7.2M -$7.2M FY21FY20: -$7.2M -$7.2M FY20FY22: $4.8M $4.8M FY22FY21: $4.8M $4.8M FY21FY22: -$1.6M -$1.6M FY22FY23: -$2.1M -$2.1M FY23FY24: -$4.2M -$4.2M FY24FY25: $4.5M $4.5M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$20.9M-$2.2M$4.5M$0.02-$5.8M
2024$7.8M-$3.3M-$4.2M-$0.02-$1.6M
2023$16.3M-$2.2M-$2.1M-$0.01-$783K
2022$26.4M-$1.8M-$1.6M-$0.01-$1.9M
2021$21.5M$565K$4.8M$0.01-$1.5M
2022n/an/a$4.8M$0.01n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 18, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 19, 2025. Not a date the company has announced. See the report calendar

Where CHUC ranks in Health care

Revenue$20.9M
#467 of 742 in Health care · Bottom 37%
Revenue growth+169.4%
#35 of 529 in Health care · Top 6%
Net margin21.5%
#58 of 541 in Health care · Top 11%
Free cash flow margin-27.7%
#343 of 488 in Health care · Bottom 30%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Fiscal yearPer sharePaid outOf profit
2022n/a$0n/a
2021n/a$883K18%
2020n/a$0n/a
2019n/a$18.4Mn/a
2018n/a$8M110%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Charlie's Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 17, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 116% to $3.8M versus the same quarter last year; diluted EPS -$0.01 versus $0.00.
  2. August 14, 2026
  3. August 4, 2026
  4. June 5, 2026
  5. May 21, 2026
  6. May 20, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 204% to $4.8M versus the same quarter last year; diluted EPS $0.00 versus $0.00.
  7. May 15, 2026
  8. April 20, 2026
  9. April 9, 2026
  10. April 1, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 4, 2026. Insider transactions on SEC

Insider trades

What the people running Charlie's Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 7 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
September 3, 2026 Carmines EdwardDirector Received as pay 200,000 - - Form 4
September 3, 2026 Cohen ScotDirector Received as pay 200,000 - - Form 4
September 3, 2026 Fox Jeffrey GDirector Received as pay 200,000 - - Form 4
September 3, 2026 King Michael DDirector Received as pay 200,000 - - Form 4
September 3, 2026 Stump RyanChief Operating Officer Received as pay 200,000 - - Form 4
September 3, 2026 Montesano Matthew PChief Financial Officer Received as pay 500,000 - - Form 4
September 3, 2026 Sicignano Henry IIIPresident Received as pay 500,000 - - Form 4
February 13, 2026 Montesano Matthew PChief Financial Officer Bought 100,000 $0.20 $20K Form 4
February 13, 2026 Sicignano Henry IIIPresident Bought 250,000 $0.20 $50K Form 4
February 13, 2026 Stump RyanChief Operating Officer Bought 250,000 $0.20 $50K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns CHUC

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

No holder of 5% or more has filed about this company in that window.

Latest filings below 5%: Richard Abbe 4.8% (May 14, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

7 insiders reported holding 28,621,860 shares in total, about $4.6M at the last price.

HolderSharesAs of
Sicignano Henry IIIPresident 10,350,001 September 3, 2026
King Michael DDirector 6,950,001 September 3, 2026
Montesano Matthew PChief Financial Officer 3,325,409 September 3, 2026
Stump RyanChief Operating Officer 2,551,968 September 3, 2026
Carmines EdwardDirector 2,356,481 September 3, 2026
Fox Jeffrey GDirector 1,650,000 September 3, 2026
Cohen ScotDirector 1,438,000 September 3, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CHUC

What does Charlie's Holdings, Inc. do?

Charlie's Holdings, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CHUC.

Is Charlie's Holdings, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $2M on revenue of $26.2M.

How much revenue does Charlie's Holdings, Inc. make?

Over the twelve months to June 30, 2026 Charlie's Holdings, Inc. reported revenue of $26.2M. That is 335.7% more than a year earlier.

When did Charlie's Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 17, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 4, 2026.

Similar companies

Compare CHUC with

Compare CHUC with any company

Follow CHUC

Get an email when Charlie's Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CHUC: get an email when it files

Where the numbers come from

Financial figures are the values Charlie's Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.